文献
J-GLOBAL ID:202002282438691411
整理番号:20A2285411
選択の初回治療としての前立腺全摘除術を受けた前立腺癌患者の尿中のインドールアミン-2,3-ジオキシゲナーゼ遺伝子発現の予後的価値【JST・京大機械翻訳】
The Prognostic Value of Indoleamine-2,3-Dioxygenase Gene Expression in Urine of Prostate Cancer Patients Undergoing Radical Prostatectomy as First Treatment of Choice
著者 (7件):
Thuering Michael
(Oncology Research Unit, Department of Urology, University Hospital of Zurich, Zurich, Switzerland)
,
Knuchel Robin
(Oncology Research Unit, Department of Urology, University Hospital of Zurich, Zurich, Switzerland)
,
Picchetta Ludovica
(Oncology Research Unit, Department of Urology, University Hospital of Zurich, Zurich, Switzerland)
,
Keller Daniel
(Oncology Research Unit, Department of Urology, University Hospital of Zurich, Zurich, Switzerland)
,
Schmidli Tobias S.
(Oncology Research Unit, Department of Urology, University Hospital of Zurich, Zurich, Switzerland)
,
Provenzano Maurizio
(Oncology Research Unit, Department of Urology, University Hospital of Zurich, Zurich, Switzerland)
,
Provenzano Maurizio
(Department of Immunology, University Hospital of Zuerich, Zurich, Switzerland)
資料名:
Frontiers in Immunology (Web)
(Frontiers in Immunology (Web))
巻:
11
ページ:
1244
発行年:
2020年
JST資料番号:
U7074A
ISSN:
1664-3224
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
スイス (CHE)
言語:
英語 (EN)